1
Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
2024
2024
Volltext
Weitere Treffer
2
Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
2024
2024
Volltext
Weitere Treffer
3
Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
2024
2024
Volltext
Weitere Treffer
4
Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
2024
2024
Volltext
Weitere Treffer
5
Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
2024
2024
Volltext
Weitere Treffer
6
Nathalie Van der Moeren, Veronica A. T. C. Weterings, Suzan D. Pas, Jaco J. Verweij, Wouter van den Bijllaardt, Joyce Geurts, Vivian F. Zwart, Esther B. Lodder, Jan A. J. W. Kluytmans, Jean-Luc Murk, Joep J. J. M. Stohr
Veröffentlicht in: Pathogens, Vol 11, Iss 1070, p 1070 (2022);
2022
Veröffentlicht in: Pathogens, Vol 11, Iss 1070, p 1070 (2022);
2022
Volltext
Weitere Treffer
Suche einschränken
Jean-Luc Murk
60
Barbara Bergmans
50
Esther de Vries
50
Eugène van Puijenbroek
50
Jette van Lint
50
Naomi Jessurun
50
Esther B. Lodder
10
Jaco J. Verweij
10
Jan A. J. W. Kluytmans
10
Joep J. J. M. Stohr
10
Joyce Geurts
10
Nathalie Van der Moeren
10
Suzan D. Pas
10
Veronica A. T. C. Weterings
10
Vivian F. Zwart
10
Wouter van den Bijllaardt
10
Medicine
55
>
50
> biologicals
50
> non
50
0 &# 8211
50
421 adrs labeled
50
5 %) reported
50
586 patients
50
Biotechnology
50
Cancer
50
Ecology
50
Immunology
50
Infectious Diseases
50
Mental Health
50
Science Policy
50
Virology
50
adverse drug reactions
50
answered bimonthly questionnaires
50
associated impact score
50
associated personal
50
average burden
50
chronic non
50
descriptive statistics
50
dutch biologic monitor
50
final analysis
50
five patients
50
gain insight
50
high impact )
50
high rate
50
high socioeconomic burden
50
increased risk
50
infectious disease professionals
50
iqr 2
50
long period
50
maybe even prevent
50
meddra code
50
median impact score
50
performed using medians
50
prospective observational study
50
remained constant
50
remained stable
50
respectively )
50
rheumatoid arthritis
50
serious infections
50
serious infections associated
50
serious infections reported
50
timely treat
50
upper respiratory tract
50
various non
50
would lessen
50